Brian Mathew
Overview
Explore the profile of Brian Mathew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gururangan K, Peschansky V, Van Hyfte G, Agarwal P, Blank L, Mathew B, et al.
J Neurol
. 2024 Apr;
271(7):3991-4007.
PMID: 38656620
Objective: To describe the frequency of neuropsychiatric complications among hospitalized patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing comorbidities and clinical outcomes. Methods: We retrospectively identified all...
2.
Ufongene C, Van Hyfte G, Agarwal P, Goldstein J, Mathew B, Navis A, et al.
Seizure
. 2023 Dec;
114:33-39.
PMID: 38039805
Background: Coronavirus disease 2019 (COVID-19) is associated with high rates of mortality and morbidity in older adults, especially those with pre-existing conditions. There is little work investigating how neurological conditions...
3.
Ufongene C, Van Hyfte G, Agarwal P, Blank L, Goldstein J, Mathew B, et al.
Epilepsia
. 2023 Jul;
64(10):2725-2737.
PMID: 37452760
Objectives: Coronavirus disease 2019 (COVID-19) is associated with mortality in persons with comorbidities. The aim of this study was to evaluate in-hospital outcomes in patients with COVID-19 with and without...
4.
Griggs E, Trageser K, Naughton S, Yang E, Mathew B, Van Hyfte G, et al.
Elife
. 2023 Jul;
12.
PMID: 37417740
Infection with the etiological agent of COVID-19, SARS-CoV-2, appears capable of impacting cognition in some patients with post-acute sequelae of SARS-CoV-2 (PASC). To evaluate neuropathophysiological consequences of SARS-CoV-2 infection, we...
5.
McCarthy L, Khegai O, Goldstein J, Belani P, Pawha P, Kihira S, et al.
PLoS One
. 2023 Mar;
18(3):e0283614.
PMID: 36961861
Introduction: Coronavirus 2019 (COVID-19) is known to affect the central nervous system. Neurologic morbidity associated with COVID-19 is commonly attributed to sequelae of some combination of thrombotic and inflammatory processes....
6.
Griggs E, Trageser K, Naughton S, Yang E, Mathew B, Van Hyfte G, et al.
bioRxiv
. 2022 Dec;
PMID: 36451886
Teaser: SARS-CoV-2 and Alzheimer's disease share similar neuroinflammatory processes, which may help explain neuro-PASC.
7.
Langan M, Smith D, Verma G, Khegai O, Saju S, Rashid S, et al.
Front Neurol
. 2022 Apr;
13:846957.
PMID: 35432151
While COVID-19 is primarily considered a respiratory disease, it has been shown to affect the central nervous system. Mounting evidence shows that COVID-19 is associated with neurological complications as well...